Assessment of drug utilization and potentially inappropriate medications in hemodialysis patients with end-stage renal dysfunction: A study in a tertiary care hospital in Bahrain
CONCLUSION: A huge burden of drug therapy was observed in the hemodialysis patients in terms of higher proportions of PIM, complex medical regimen, and prescription of drugs with risk of TdP. Implementation of clinical decision support tools enhancing rational prescription and identification of drugs with TdP risk, introducing antimicrobial stewardship, and stepwise deprescription of the drugs with the least benefit-risk ratio are warranted.PMID:38393922 | DOI:10.3233/JRS-230004
Source: International Journal of Risk and Safety in Medicine - Category: Drugs & Pharmacology Authors: Kannan Sridharan Source Type: research
More News: Allopurinol | Atorvastatin Calcium | Bahrain Health | Canada Health | Cardiology | Cardiovascular | Celebrex | Diabetes | Dialysis | Drugs & Pharmacology | Endocrinology | Furosemide | Heart | Hemodialysis | Lipitor | Lyrica | Middle East Health | Omeprazole | Prilosec | Proton Pump Inhibitors PPIs | Statin Therapy | Study | Toxicology | Urology & Nephrology | Zivast